Sensei

Sensei (先生) is a Japanese word that is literally translated as "person born before another". In general usage, it is used, with proper form, after a person's name, and means "teacher", and the word is used as a title to refer to or address teachers, professors, professionals such as lawyers, CPA, doctors, politicians, clergymen, and other figures of authority. The word is also used to show respect to someone who has achieved a certain level of mastery in an art form or some other skill: accomplished novelists, musicians, artists and martial artists, for example, are addressed in this way.

Etymology

The two characters that make up the term can be directly translated as "born before" and implies one who teaches based on wisdom from age and experience.

The word prefaced by the adjective 大, pronounced "dai" (or "ō"), which means "great" or "large", is often translated "grand master". This compound term, "dai-sensei", is sometimes used to refer to the top sensei in a particular school or tradition, particularly within the iemoto system. For a more senior member of a group who has not achieved the level of sensei, the term senpai (先輩) is used – note the common use of 先 "before"; in martial arts, this is particularly used for the most senior non-sensei member.

Ōsensei

Ōsensei (大先生/翁先生 great teacher, grand master) is a Japanese term, a stronger form of sensei (先生 teacher).

The term is used in the iemoto system to refer to the senior sensei in an organization, and is also commonly used to refer to certain founders of martial arts schools, namely:

  • Morihei Ueshiba, founder of Aikido
  • Masutatsu Oyama, founder of Kyokushinkai karate
  • Japanese honorifics

    The Japanese language uses a broad array of honorific suffixes for addressing or referring to people. These honorifics attach to the end of people's names, as in Aman-san where the honorific -san was attached to the name Aman. These honorifics are often gender-neutral, but some imply a more feminine context (such as -chan) while others imply a more masculine one (such as -kun).

    These honorifics are often used along with other forms of Japanese honorific speech, keigo, such as that used in conjugating verbs.

    Usage

    Although honorifics are not part of the basic grammar of the Japanese language, they are a fundamental part of the sociolinguistics of Japanese, and proper use is essential to proficient and appropriate speech. Significantly, referring to oneself using an honorific, or dropping an honorific when it is required, is a serious faux pas, in either case coming across as clumsy or arrogant.

    They can be applied to either the first or last name depending on which is given. In situations where both the first and last names are spoken, the suffix is attached to whichever comes last in the word order.

    Podcasts:

    PLAYLIST TIME:

    Latest News for: and or sensei

    Edit

    SENSEI | Masters of Okinawan Karate Series Two #5 - Morio Higaonna | 沖縄空手 剛柔流 ...

    Bitchute 31 Mar 2025
    Go to the source via the article link to view the video or click the video icon ....
    Edit

    SENSEI: Masters of Okinawan Karate Series Two #4 - Hidetada Ishiki

    Bitchute 31 Mar 2025
    Go to the source via the article link to view the video or click the video icon ....
    Edit

    Lead Sensei LLC Sets New Standard for Small Business Solutions Nationwide

    Nasdaq Globe Newswire 28 Mar 2025
    Atlanta-based�Lead Sensei LLC�is answering that call, offering an all-in-one ...
    Edit

    Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress

    Nasdaq Globe Newswire 28 Mar 2025
    - Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor patient population - ... .
    Edit

    Solnerstotug: Preliminary Dose Expansion Data (Sensei Biotherapeutics Inc)

    Public Technologies 28 Mar 2025
    ). The text version of this document is not available ... Sensei Biotherapeutics Inc.
    Edit

    Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress (Form 8-K) (Sensei Biotherapeutics Inc)

    Public Technologies 28 Mar 2025
    Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress ... BOSTON, MA - March 28, 2025- Sensei Biotherapeutics, Inc ... Sensei presented new data and mechanistic insights across multiple forums in 2024.
    Edit

    Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress (Sensei Biotherapeutics Inc)

    Public Technologies 28 Mar 2025
    BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc ... In March 2025, Sensei presented preliminary dose expansion data showing, as of the data cutoff of March 17, 2025. ... About Sensei Biotherapeutics. Sensei Biotherapeutics (Nasdaq.
    Edit

    Initial Registration Statement for Employee Benefit Plan (Form S-8) (Sensei Biotherapeutics Inc)

    Public Technologies 28 Mar 2025
    SENSEI BIOTHERAPEUTICS, INC ... Sensei Biotherapeutics, Inc ... Sensei Biotherapeutics, Inc ... to be issued pursuant to the 2021 Equity Incentive Plan ("2021 EIP") and (ii) 251,805 shares of Common Stock of Sensei Biotherapeutics, Inc.
    Edit

    Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K) (Sensei Biotherapeutics Inc)

    Public Technologies 28 Mar 2025
    ). Management's Discussion and Analysis ofFinancial Condition and Results of Operations ... Overview ... Our strategy is to generate novel product candidates that incorporate next-generation technologies or approaches ... Income Taxes ... Sensei Biotherapeutics Inc.
    Edit

    Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors

    Nasdaq Globe Newswire 27 Mar 2025
    Initial clinical activity in a PD-(L)1 resistant population, with an ORR almost three times higher than historical PD-(L)1 rechallenge response rates, with data still maturing – ... .
    Edit

    Sensei Company Presentation March 2025 (Sensei Biotherapeutics Inc)

    Public Technologies 27 Mar 2025
    Sensei Investment Highlights ... *Sensei has entered into a clinical supply agreement with Regeneron supporting the planned evaluation of solnerstotug in combination with ... Sensei Biotherapeutics Inc.
    Edit

    Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors (Form 8-K) (Sensei Biotherapeutics Inc)

    Public Technologies 27 Mar 2025
    Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors ... - Sensei to host investor webcast today at 5.30 p.m ... BOSTON, MA - March 27, 2025 - Sensei Biotherapeutics, Inc.
    Edit

    Fine Tune Nutrition at Sensei Lanai, A Four Seasons Resort (Four Seasons Hotels Inc)

    Public Technologies 27 Mar 2025
    A Hawaiian vacation might not seem like the perfect time and place to examine healthy eating habits, but at Sensei Lanai, A Four Seasons Resort, there's never a bad time to focus on nutrition.
    Edit

    Preliminary Dose Expansion Data (Sensei Biotherapeutics Inc)

    Public Technologies 27 Mar 2025
    ). SNS-101 Dose Expansion Data. March 27, 2025. Presenters.. Dr. Shiraj Sen ... John Celebi. Chief Executive Officer. Ron Weitzman. Chief Medical Officer ... 2017 ... … ... Given prior history of VISTA antibodies, Sensei prioritized establishing. ... Sensei Biotherapeutics Inc.
    ×